Variant report
Variant | nsv825698 |
---|---|
Chromosome Location | chr1:189551952-189577105 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371359205 | chr1:189552218-189552219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs117252348 | chr1:189552271-189552272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs149730936 | chr1:189552310-189552311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532736035 | chr1:189552328-189552329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552598689 | chr1:189552344-189552345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563155335 | chr1:189552372-189552373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531622078 | chr1:189552373-189552374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548148699 | chr1:189552399-189552400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78001212 | chr1:189552403-189552404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190700754 | chr1:189552474-189552475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs41512846 | chr1:189552536-189552537 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs566554571 | chr1:189552546-189552547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs445857 | chr1:189552579-189552580 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs431889 | chr1:189552599-189552600 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs116049600 | chr1:189552602-189552603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78426794 | chr1:189552628-189552629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554641306 | chr1:189552648-189552649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574476835 | chr1:189552650-189552651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183216565 | chr1:189552673-189552674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs553782634 | chr1:189552704-189552705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74607178 | chr1:189552754-189552755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187930307 | chr1:189552764-189552765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369940962 | chr1:189552769-189552770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74138434 | chr1:189552791-189552792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs73047495 | chr1:189552817-189552818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12042623 | chr1:189552847-189552848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7538931 | chr1:189552856-189552857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs16830864 | chr1:189552857-189552858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs400172 | chr1:189552871-189552872 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs34391030 | chr1:189552921-189552922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547497231 | chr1:189552943-189552944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560495564 | chr1:189552986-189552987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34332072 | chr1:189553022-189553023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs202242901 | chr1:189553023-189553024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148490116 | chr1:189553052-189553053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184666851 | chr1:189553063-189553064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145283898 | chr1:189553090-189553091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74565609 | chr1:189553099-189553100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs369036044 | chr1:189553141-189553142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552378980 | chr1:189553160-189553161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568944618 | chr1:189553177-189553178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs372861736 | chr1:189555232-189555233 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375605148 | chr1:189555233-189555234 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12042405 | chr1:189555246-189555247 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141962381 | chr1:189555257-189555258 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143653314 | chr1:189555264-189555265 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550143474 | chr1:189555268-189555269 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
48 | rs61818929 | chr1:189555272-189555273 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558441798 | chr1:189555274-189555275 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
50 | rs201175930 | chr1:189555275-189555276 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:189552200-189553200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr1:189555200-189555400 | Flanking Bivalent TSS/Enh | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr1:189565200-189566800 | Enhancers | HUVEC | blood vessel |
4 | chr1:189566400-189566800 | Active TSS | A549 | lung |
5 | chr1:189574200-189575400 | Enhancers | A549 | lung |
6 | chr1:189574200-189576600 | Enhancers | Hela-S3 | cervix |
7 | chr1:189574200-189577200 | Enhancers | HMEC | breast |
8 | chr1:189574400-189574600 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr1:189574800-189575800 | Weak transcription | Muscle Satellite Cultured Cells | -- |
10 | chr1:189575200-189575600 | Enhancers | Fetal Brain Male | brain |
11 | chr1:189575400-189576200 | Flanking Active TSS | A549 | lung |
12 | chr1:189575800-189576800 | Enhancers | NH-A | brain |
13 | chr1:189575800-189578800 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr1:189576000-189576800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
15 | chr1:189576200-189576400 | Active TSS | A549 | lung |
16 | chr1:189576400-189576600 | Flanking Active TSS | A549 | lung |
17 | chr1:189576600-189576800 | Active TSS | A549 | lung |
18 | chr1:189576600-189577000 | Enhancers | Osteobl | bone |
19 | chr1:189576800-189577400 | Flanking Active TSS | A549 | lung |